HighVista Strategies LLC recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
200 CLARENDON STREET, 50TH FLOOR BOSTON, MA 02116
As of the latest 13F report, the guru’s equity portfolio contained 105 stocks valued at a total of $168.00Mil. The top holdings were DELL(8.49%), MA(7.68%), and V(5.24%).
According to GuruFocus data, these were HighVista Strategies LLC’s top five trades of the quarter.
Change Healthcare Inc
The guru sold out of their 162,100-share investment in NAS:CHNG. Previously, the stock had a 2.55% weight in the equity portfolio. Shares traded for an average price of $27.49 during the quarter.
On 02/18/2023, Change Healthcare Inc traded for a price of $27.49 per share and a market cap of $9.03Bil. The stock has returned 30.16% over the past year.
GuruFocus gives the company a financial strength rating of 3 out of 10 and a profitability rating of 3 out of 10.
In terms of valuation, Change Healthcare Inc has a price-book ratio of 2.73, a EV-to-Ebitda ratio of 16.98 and a price-sales ratio of 2.55.
Cytokinetics Inc
The guru sold out of their 73,154-share investment in NAS:CYTK. Previously, the stock had a 2.02% weight in the equity portfolio. Shares traded for an average price of $42.95 during the quarter.
On 02/18/2023, Cytokinetics Inc traded for a price of $45.71 per share and a market cap of $4.33Bil. The stock has returned 29.78% over the past year.
GuruFocus gives the company a financial strength rating of 3 out of 10 and a profitability rating of 2 out of 10.
In terms of valuation, Cytokinetics Inc has a EV-to-Ebitda ratio of -17.31 and a price-sales ratio of 26.28.
The price-to-GF Value ratio is 1.23, earning the stock a GF Value rank of 3.
Nielsen Holdings PLC
The guru sold out of their 114,200-share investment in NYSE:NLSN. Previously, the stock had a 1.81% weight in the equity portfolio. Shares traded for an average price of $27.94 during the quarter.
On 02/18/2023, Nielsen Holdings PLC traded for a price of $27.98 per share and a market cap of $10.07Bil. The stock has returned 43.76% over the past year.
GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 6 out of 10.
In terms of valuation, Nielsen Holdings PLC has a price-earnings ratio of 19.03, a price-book ratio of 2.90, a price-earnings-to-growth (PEG) ratio of 14.85, a EV-to-Ebitda ratio of 11.37 and a price-sales ratio of 2.86.
The price-to-GF Value ratio is 1.25, earning the stock a GF Value rank of 1.
Axsome Therapeutics Inc
During the quarter, HighVista Strategies LLC bought 38,238 shares of NAS:AXSM for a total holding of 55,124. The trade had a 1.75% impact on the equity portfolio. During the quarter, the stock traded for an average price of $59.77.
On 02/18/2023, Axsome Therapeutics Inc traded for a price of $66.62 per share and a market cap of $2.89Bil. The stock has returned 119.07% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 1 out of 10.
In terms of valuation, Axsome Therapeutics Inc has a price-book ratio of 18.40, a EV-to-Ebitda ratio of -17.81 and a price-sales ratio of 102.61.
South Jersey Industries Inc
The guru established a new position worth 79,500 shares in NYSE:SJI, giving the stock a 1.68% weight in the equity portfolio. Shares traded for an average price of $34.55 during the quarter.
On 02/18/2023, South Jersey Industries Inc traded for a price of $36.09 per share and a market cap of $4.42Bil. The stock has returned 57.25% over the past year.
GuruFocus gives the company a financial strength rating of 3 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, South Jersey Industries Inc has a price-earnings ratio of 26.54, a price-book ratio of 2.15, a price-earnings-to-growth (PEG) ratio of 2.00, a EV-to-Ebitda ratio of 16.70 and a price-sales ratio of 1.66.
The price-to-GF Value ratio is 1.10, earning the stock a GF Value rank of 3.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
